Bank of New York Mellon Corp - TANDEM DIABETES CARE INC ownership

TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 394 filers reported holding TANDEM DIABETES CARE INC in Q4 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of TANDEM DIABETES CARE INC
ValueSharesWeighting
Q3 2023$10,689,427
-15.5%
514,657
-0.2%
0.00%
-33.3%
Q2 2023$12,651,461
-47.2%
515,545
-12.7%
0.00%
-40.0%
Q1 2023$23,983,453
-16.6%
590,580
-7.7%
0.01%
-28.6%
Q4 2022$28,755,771
-8.1%
639,728
-2.2%
0.01%
-12.5%
Q3 2022$31,283,000
-16.9%
653,808
+2.8%
0.01%
-11.1%
Q2 2022$37,650,000
-47.2%
636,066
+3.6%
0.01%
-35.7%
Q1 2022$71,372,000
-22.3%
613,747
+0.6%
0.01%
-17.6%
Q4 2021$91,803,000
+32.4%
609,911
+5.0%
0.02%
+21.4%
Q3 2021$69,323,000
+193.1%
580,695
+139.1%
0.01%
+180.0%
Q2 2021$23,654,000
+1.8%
242,857
-7.7%
0.01%0.0%
Q1 2021$23,226,000
+8.2%
263,189
+17.3%
0.01%0.0%
Q4 2020$21,466,000
-16.0%
224,349
-0.3%
0.01%
-16.7%
Q3 2020$25,541,000
+16.4%
225,025
+1.5%
0.01%0.0%
Q2 2020$21,938,000
+30.3%
221,785
-15.3%
0.01%0.0%
Q1 2020$16,842,000
+15.1%
261,703
+6.6%
0.01%
+50.0%
Q4 2019$14,630,000
-2.6%
245,435
-3.7%
0.00%0.0%
Q3 2019$15,026,000
-5.7%
254,761
+3.2%
0.00%0.0%
Q2 2019$15,932,000
+3.7%
246,930
+2.0%
0.00%0.0%
Q1 2019$15,368,000
+61.7%
242,023
-3.3%
0.00%
+33.3%
Q4 2018$9,502,000
+5.1%
250,256
+18.6%
0.00%
+50.0%
Q3 2018$9,039,000
+100.5%
210,992
+3.1%
0.00%
+100.0%
Q2 2018$4,508,000
+1747.5%
204,679
+314.6%
0.00%
Q1 2018$244,00049,3650.00%
Other shareholders
TANDEM DIABETES CARE INC shareholders Q4 2021
NameSharesValueWeighting ↓
Delphi Management Partners VIII, L.L.C. 1,000,000$59,610,00047.04%
Prospect Capital Advisors, LLC 127,900$7,624,0004.68%
Asymmetry Capital Management, L.P. 43,559$2,597,0004.66%
Copernicus Capital Management, LLC 50,000$2,981,0003.91%
SECTORAL ASSET MANAGEMENT INC 341,714$20,370,0003.04%
FRIESS ASSOCIATES LLC 627,225$37,389,0002.60%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,361,345$81,150,0002.59%
Parkman Healthcare Partners LLC 134,959$8,045,0002.32%
OBERWEIS ASSET MANAGEMENT INC/ 109,940$6,554,0002.18%
First Light Asset Management, LLC 268,574$16,010,0002.05%
View complete list of TANDEM DIABETES CARE INC shareholders